FINAFLEX Engage Sour Watermelon product packaging

Image: NIH Office of Dietary Supplements, Dietary Supplement Label DatabaseNo separate image reuse license stated

FINAFLEX

Engage Sour Watermelon

Powder

Serving size13.7 Gram(s) [2 Scoops (27.4g)]
Servings per containerNot listed
Package19.3 Ounce(s); 548 Gram(s)
Data retrievedJul 28, 2026

Checking your goal…

Checking with your list…

1 labeled serving/day preview
Open the complete check →

Supplement Facts

Serving size 13.7 Gram(s) [2 Scoops (27.4g)]

Total CarbohydratesNot listedDV not established
Creatine Monohydrate5.3 gDV not established
L-Citrulline Malate4 gDV not established
Beta-Alanine1.6 gDV not established
Alpha-Glycerylphosphorylcholine600 mgDV not established
Caffeine180 mgDV not established

Other ingredients

Natural & Artificial Flavors; Other Natural Flavors; Citric Acid; Silica; Calcium Silicate (Ca Silicate); Sucralose

Label directions

Suggested use:As a dietary supplement mix 1 serving (2 scoops) in 8-16 fl oz of water. Start wtih 1/2 serving (1 scoop) to access tolerance.15-30 minDrink 15-30 minutes prior to engaging in any physical activity; and get ready for your most extreme workout yet!

Label warnings

Allergen Warning: Produced in a facility that processes milk eggs soybeans wheat shellfish fish oil tree nuts sesame and peanuts. Warning: Not for the weak Warning: Keep out of reach of children. Intended for healthy adults over 18. Do not use if pregnant or nursing. Consult a doctor or medical authority before use if you have a medical condition a family history of health problems or if you take other medicines or supplements. Do not exceed serving size. Stop use if you have a bad reaction. Stop use after 8 weeks. Stop use 2 weeks before surgery. Do not combine with caffeine stimulants or alcohol. May cause a harmless tingling. Consumer accepts all liability if used inconsistent with label. Do not discard desiccant. 360 mg caffeine per serving. CA Prop 65 Warning: LeadCancer and Reproductive Harm www.P65Warnings.ca.gov/food.

Identity and label version

NIH label record333672
Entered into NIH DSLDJul 24, 2025
UPC / GTIN00810020722871
Manufacturer / distributor on labelFINAFLEX
Market statusOn market in the source data
“Entered into NIH DSLD” is the database entry date for this label record. It is not a manufacturer launch date or a label effective date.

NIH label history (1)

Current labelNIH record 333672Entered Jul 24, 2025
Serving size13.7 Gram(s) [2 Scoops (27.4g)]
Formula versionb75242b2
Ingredients on label6
NIH sourceOpen label ↗
Total CarbohydratesNot listed
Creatine Monohydrate5.3 g
L-Citrulline Malate4 g
Beta-Alanine1.6 g
Alpha-Glycerylphosphorylcholine600 mg
Caffeine180 mg

Label warning: Allergen Warning: Produced in a facility that processes milk eggs soybeans wheat shellfish fish oil tree nuts sesame and peanuts. Warning: Not for the weak Warning: Keep out of reach of children. Intended for healthy adults over 18. Do not use if pregnant or nursing. Consult a doctor or medical authority before use if you have a medical condition a family history of health problems or if you take other medicines or supplements. Do not exceed serving size. Stop use if you have a bad reaction. Stop use after 8 weeks. Stop use 2 weeks before surgery. Do not combine with caffeine stimulants or alcohol. May cause a harmless tingling. Consumer accepts all liability if used inconsistent with label. Do not discard desiccant. 360 mg caffeine per serving. CA Prop 65 Warning: LeadCancer and Reproductive Harm www.P65Warnings.ca.gov/food.

Sources and traceability

  • NIH Dietary Supplement Label DatabaseData retrieved Jul 28, 2026
    Open source ↗

More from FINAFLEX

Data comes from product labels or official public sources. It does not mean Safmira, NIH, or FDA approves, certifies, or recommends this product. Label amounts are not laboratory measurements.